List of All Referred Studies

List of all referred studies

Abe, K., M. Okano, and H. Sasaki. "Phenytoin Elimination Kinetics in Two Children with Drug Intoxication." Eur J Pediatr 135, no. 1 (1980): 69-71.

Adityanjee. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (Silent)." Pharmacopsychiatry 22, no. 2 (1989): 81-3.

Adityanjee, K. R. Munshi, and A. Thampy. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity." Clin Neuropharmacol 28, no. 1 (2005): 38-49.

Agrawal, B. L. "Ataxia Caused by Fluoxymesterone Therapy in Breast Cancer." Arch Intern Med 141, no. 7 (1981): 958-9.

Alioglu, Z., A. Sari, S. K. Velioglu, Ouml, and M. zmenoglu. "Cerebellar Atrophy Following Acute Phenytoin Intoxication." J Neuroradiol 27, no. 1 (2000): 52-5.

Alkawi, A., J. C. Kattah, and K. Wyman. "Downbeat Nystagmus as a Result of Lamotrigine Toxicity." Epilepsy Res 63, no. 2-3 (2005): 85-8.

Andrade, C., B. N. Gangadhar, and S. M. Channabasavanna. "Pathological Neurotoxicity with Lithium." Indian J Psychiatry 29, no. 3 (1987): 279-81.

Anhut, H., P. Ashman, T. J. Feuerstein, W. Sauermann, M. Saunders, and B. Schmidt. "Gabapentin (Neurontin) as Add-on Therapy in Patients with Partial Seizures: A Double-Blind, Placebo-Controlled Study. The International Gabapentin Study Group." Epilepsia 35, no. 4 (1994): 795-801.

Apte, S. N., and J. W. Langston. "Permanent Neurological Deficits Due to Lithium Toxicity." Ann Neurol 13, no. 4 (1983): 453-5.

Ardalan, B., G. Singh, and H. Silberman. "A Randomized Phase I and Ii Study of Short-Term Infusion of High-Dose Fluorouracil with or without N-(Phosphonacetyl)-L-Aspartic Acid in Patients with Advanced Pancreatic and Colorectal Cancers." J Clin Oncol 6, no. 6 (1988): 1053-8.

Arezzo, J. C., J. Rosenstock, L. Lamoreaux, and L. Pauer. "Efficacy and Safety of Pregabalin 600 Mg/D for Treating Painful Diabetic Peripheral Neuropathy: A Double-Blind Placebo-Controlled Trial." BMC Neurol 8, (2008): 33.

Armour, D. J., C. Fidler, E. C. Wright, and S. Balarajan. "Vigabatrin in Adults with Poorly-Controlled Epilepsy and Learning Disabilities." Seizure 1, no. 3 (1992): 157-62.

Arroyo, S., H. Anhut, A. R. Kugler, C. M. Lee, L. E. Knapp, E. A. Garofalo, S. Messmer, and Group Pregabalin -011 International Study. "Pregabalin Add-on Treatment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study in Adults with Partial Seizures." Epilepsia 45, no. 1 (2004): 20-7.

Arya, D. K. "Lithium-Induced Neurotoxicity at Serum Lithium Levels within the Therapeutic Range." Aust N Z J Psychiatry 30, no. 6 (1996): 871-3.

Atkins, J. N., H. B. Muss, D. Case, J. Brockschmidt, F. M. Schnell, M. O'Rourke, T. H. Grote, J. H. West, S. Anthony, and V. Stanley. "High-Dose 24-Hour Infusion of 5-Fluorouracil in Metastatic Prostate Cancer. A Phase Ii Trial of the Piedmont Oncology Association." Am J Clin Oncol 14, no. 6 (1991): 526-9.

Atkinson, K., J. Biggs, P. Darveniza, J. Boland, A. Concannon, and A. Dodds. "Spinal Cord and Cerebellar-Like Syndromes Associated with the Use of Cyclosporine in Human Recipients of Allogeneic Marrow Transplants." Transplant Proc 17, no. 2 (1985): 1673-5.

Awada, A., P. Amene, M. al Jumah, and K. al Beladi. "[Residual Cerebellar Ataxia Following Acute Phenytoin Intoxication]." Rev Neurol (Paris) 155, no. 4 (1999): 306-8.

Aylett, S. E., H. Cross, and D. Berry. "Eye Rolling as a Manifestation of Clobazam Toxicity in a Child with Epilepsy." Dev Med Child Neurol 48, no. 7 (2006): 612-5.

Baath, N. S., J. Hong, and S. P. Sattar. "Possible Carbamazepine Toxicity with Terbinafine." Can J Clin Pharmacol 13, no. 2 (2006): e228-31.

Baier, W. K., U. Beck, H. Doose, H. Klinge, and W. Hirsch. "Cerebellar Atrophy Following Diphenylhydantoin Intoxication." Neuropediatrics 15, no. 2 (1984): 76-81.

Baier, W. K., U. Beck, and W. Hirsch. "Ct Findings Following Diphenylhydantoin Intoxication." Pediatr Radiol 15, no. 4 (1985): 220-1.

Barcs, G., E. B. Walker, C. E. Elger, A. Scaramelli, H. Stefan, Y. Sturm, A. Moore, G. Flesch, L. Kramer, and J. D'Souza. "Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy." Epilepsia 41, no. 12 (2000): 1597-607.

Baulac, M., D. Cavalcanti, F. Semah, A. Arzimanoglou, and J. J. Portal. "Gabapentin Add-on Therapy with Adaptable Dosages in 610 Patients with Partial Epilepsy: An Open, Observational Study. The French Gabapentin Collaborative Group." Seizure 7, no. 1 (1998): 55-62.

Baulac, M., T. Leon, T. J. O'Brien, E. Whalen, and J. Barrett. "A Comparison of Pregabalin, Lamotrigine, and Placebo as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures." Epilepsy Res 91, no. 1 (2010): 10-9.

Baz, D. V., J. S. Bofill, and J. A. Nogueira. "Irinotecan-Induced Dysarthria." J Natl Cancer Inst 93, no. 18 (2001): 1419-20.

Beattie, B., J. Biller, B. Mehlhaus, and M. Murray. "Verapamil-Induced Carbamazepine Neurotoxicity. A Report of Two Cases." Eur Neurol 28, no. 2 (1988): 104-5.

Bechstein, W. O. "Neurotoxicity of Calcineurin Inhibitors: Impact and Clinical Management." Transpl Int 13, no. 5 (2000): 313-26.

Belli, L. S., L. De Carlis, F. Romani, G. F. Rondinara, P. Rimoldi, A. Alberti, G. Bettale, L. Dughetti, G. Ideo, M. Sberna, and et al. "Dysarthria and Cerebellar Ataxia: Late Occurrence of Severe Neurotoxicity in a Liver Transplant Recipient." Transpl Int 6, no. 3 (1993): 176-8.

Ben-Menachem, E., V. Biton, D. Jatuzis, B. Abou-Khalil, P. Doty, and G. D. Rudd. "Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial-Onset Seizures." Epilepsia 48, no. 7 (2007): 1308-17.

Ben-Menachem, E., A. A. Gabbai, A. Hufnagel, J. Maia, L. Almeida, and P. Soares-da-Silva. "Eslicarbazepine Acetate as Adjunctive Therapy in Adult Patients with Partial Epilepsy." Epilepsy Res 89, no. 2-3 (2010): 278-85.

Ben-Menachem, E., O. Henriksen, M. Dam, M. Mikkelsen, D. Schmidt, S. Reid, R. Reife, L. Kramer, G. Pledger, and R. Karim. "Double-Blind, Placebo-Controlled Trial of Topiramate as Add-on Therapy in Patients with Refractory Partial Seizures." Epilepsia 37, no. 6 (1996): 539-43.

Bendiksen, A., and L. M. Larsen. "Convulsions, Ataxia and Hallucinations Following Propofol." Acta Anaesthesiol Scand 42, no. 6 (1998): 739-41.

Beran, R., S. Berkovic, A. Black, G. Danta, J. Dunne, J. Frasca, K. Grainger, C. Kilpatrick, R. McKenzie, D. McLaughlin, G. Schapel, and E. Somerville. "Australian Study of Titration to Effect Profile of Safety (Aus-Steps): High-Dose Gabapentin (Neurontin) in Partial Seizures." Epilepsia 42, no. 10 (2001): 1335-9.

Beran, R. G., S. F. Berkovic, N. Buchanan, G. Danta, R. Mackenzie, G. Schapel, G. Sheean, and F. Vajda. "A Double-Blind, Placebo-Controlled Crossover Study of Vigabatrin 2 G/Day and 3 G/Day in Uncontrolled Partial Seizures." Seizure 5, no. 4 (1996): 259-65.

Beran, R. G., S. F. Berkovic, F. M. Dunagan, F. J. Vajda, G. Danta, A. B. Black, and R. Mackenzie. "Double-Blind, Placebo-Controlled, Crossover Study of Lamotrigine in Treatment-Resistant Generalised Epilepsy." Epilepsia 39, no. 12 (1998): 1329-33.

Bernstein, A. L., and J. L. Leventhal-Rochon. "Neurotoxicity Related to the Use of Topical Tretinoin (Retin-a)." Ann Intern Med 124, no. 2 (1996): 227-8.

Betts, T., G. Goodwin, R. M. Withers, and A. W. Yuen. "Human Safety of Lamotrigine." Epilepsia 32 Suppl 2, (1991): S17-21.

Beydoun, A., B. M. Uthman, A. R. Kugler, M. J. Greiner, L. E. Knapp, E. A. Garofalo, and Group Pregabalin -009 Study. "Safety and Efficacy of Two Pregabalin Regimens for Add-on Treatment of Partial Epilepsy." Neurology 64, no. 3 (2005): 475-80.

Binnie, C. D., R. M. Debets, M. Engelsman, J. W. Meijer, H. Meinardi, J. Overweg, A. W. Peck, A. Van Wieringen, and W. C. Yuen. "Double-Blind Crossover Trial of Lamotrigine (Lamictal) as Add-on Therapy in Intractable Epilepsy." Epilepsy Res 4, no. 3 (1989): 222-9.

Binnie, C. D., W. van Emde Boas, D. G. Kasteleijn-Nolste-Trenite, R. A. de Korte, J. W. Meijer, H. Meinardi, A. A. Miller, J. Overweg, A. W. Peck, A. van Wieringen, and et al. "Acute Effects of Lamotrigine (Bw430c) in Persons with Epilepsy." Epilepsia 27, no. 3 (1986): 248-54.

Biton, V., A. Gil-Nagel, M. J. Brodie, S. E. Derossett, and V. Nohria. "Safety and Tolerability of Different Titration Rates of Retigabine (Ezogabine) in Patients with Partial-Onset Seizures." Epilepsy Res 107, no. 1-2 (2013): 138-45.

Blanche, P., E. Raynaud, D. Kerob, and N. Galezowski. "Lithium Intoxication in an Elderly Patient after Combined Treatment with Losartan." Eur J Clin Pharmacol 52, no. 6 (1997): 501.

Boas, J., M. Dam, M. L. Friis, O. Kristensen, B. Pedersen, and J. Gallagher. "Controlled Trial of Lamotrigine (Lamictal) for Treatment-Resistant Partial Seizures." Acta Neurol Scand 94, no. 4 (1996): 247-52.

Boesen, P., J. Fallingborg, and E. Spaun. "Severe Persistent Cerebellar Dysfunction Complicating Cytosine Arabinoside Therapy." Acta Med Scand 224, no. 2 (1988): 189-91.

Bollen, E., and J. B. Lanser. "Reversible Mental Deterioration and Neurological Disturbances with O,P'-Ddd Therapy." Clin Neurol Neurosurg 94 Suppl, (1992): S49-51.

Bos, M. J., A. W. de Weerd, and E. E. Hagebeuk. "[Staring Episodes in Children with Developmental Disorders: Epilepsy or Behaviour?]." Ned Tijdschr Geneeskd 155, (2011): A2473.

Bosso, J. A., C. A. Liptak, D. K. Seilheimer, and G. M. Harrison. "Toxicity of Colistin in Cystic Fibrosis Patients." DICP 25, no. 11 (1991): 1168-70.

Botez, M. I., J. Gravel, E. Attig, and J. L. Vezina. "Reversible Chronic Cerebellar Ataxia after Phenytoin Intoxication: Possible Role of Cerebellum in Cognitive Thought." Neurology 35, no. 8 (1985): 1152-7.

Brodie, M. J. "Lamotrigine--an Update." Can J Neurol Sci 23, no. 4 Suppl 2 (1996): S6-9.

Brodie, M. J., H. Lerche, A. Gil-Nagel, C. Elger, S. Hall, P. Shin, V. Nohria, H. Mansbach, and Restore Study Group. "Efficacy and Safety of Adjunctive Ezogabine (Retigabine) in Refractory Partial Epilepsy." Neurology 75, no. 20 (2010): 1817-24.

Browne, T. R., R. H. Mattson, J. K. Penry, D. B. Smith, D. M. Treiman, B. J. Wilder, E. Ben-Menachem, R. M. Miketta, K. M. Sherry, and G. K. Szabo. "A Multicentre Study of Vigabatrin for Drug-Resistant Epilepsy." Br J Clin Pharmacol 27 Suppl 1, (1989): 95S-100S.

Buckler, R. A., and J. H. Friedman. "Maprotiline-Induced Ataxia." J Clin Psychopharmacol 6, no. 6 (1986): 382-3.

Cachat, F., and A. Tufro. "Phenytoin/Isradipine Interaction Causing Severe Neurologic Toxicity." Ann Pharmacother 36, no. 9 (2002): 1399-402.

Cereghino, J. J., V. Biton, B. Abou-Khalil, F. Dreifuss, L. J. Gauer, and I. Leppik. "Levetiracetam for Partial Seizures: Results of a Double-Blind, Randomized Clinical Trial." Neurology 55, no. 2 (2000): 236-42.

Cerqueira, A. C., M. C. Reis, F. D. Novis, J. M. Bezerra, G. C. Magalhaes, M. Rozenthal, and A. E. Nardi. "Cerebellar Degeneration Secondary to Acute Lithium Carbonate Intoxication." Arq Neuropsiquiatr 66, no. 3A (2008): 578-80.

Chacko, J., K. Pramod, S. Sinha, J. Saini, A. Mahadevan, R. D. Bharath, P. S. Bindu, T. C. Yasha, and A. B. Taly. "Clinical, Neuroimaging and Pathological Features of 5-Nitroimidazole-Induced Encephalo-Neuropathy in Two Patients: Insights into Possible Pathogenesis." Neurol India 59, no. 5 (2011): 743-7.

Chan, K., and R. G. Beran. "Value of Therapeutic Drug Level Monitoring and Unbound (Free) Levels." Seizure 17, no. 6 (2008): 572-5.

Chappell, A. S., J. W. Sander, M. J. Brodie, D. Chadwick, A. Lledo, D. Zhang, J. Bjerke, G. M. Kiesler, and S. Arroyo. "A Crossover, Add-on Trial of Talampanel in Patients with Refractory Partial Seizures." Neurology 58, no. 11 (2002): 1680-2.

Charness, M. E., F. Morady, and M. M. Scheinman. "Frequent Neurologic Toxicity Associated with Amiodarone Therapy." Neurology 34, no. 5 (1984): 669-71.

Choi, J. Y., Y. M. Park, Y. S. Woo, S. U. Kim, J. M. Jung, and D. Y. Kwon. "Perverted Head-Shaking and Positional Downbeat Nystagmus in Pregabalin Intoxication." J Neurol Sci 337, no. 1-2 (2014): 243-4.

Chung, S., M. R. Sperling, V. Biton, G. Krauss, D. Hebert, G. D. Rudd, P. Doty, and S. P. Study Group. "Lacosamide as Adjunctive Therapy for Partial-Onset Seizures: A Randomized Controlled Trial." Epilepsia 51, no. 6 (2010): 958-67.

Cocito, L., M. Maffini, and C. Loeb. "Long-Term Observations on the Clinical Use of Lamotrigine as Add-on Drug in Patients with Epilepsy." Epilepsy Res 19, no. 2 (1994): 123-7.

Cocito, L., M. Maffini, P. Perfumo, F. Roncallo, and C. Loeb. "Vigabatrin in Complex Partial Seizures: A Long-Term Study." Epilepsy Res 3, no. 2 (1989): 160-6.

Cohen, W. J., and N. H. Cohen. "Lithium Carbonate, Haloperidol, and Irreversible Brain Damage." JAMA 230, no. 9 (1974): 1283-7.

Coldwell, S. E., K. Awamura, P. Milgrom, K. S. Depner, E. Kaufman, K. L. Preston, and H. W. Karl. "Side Effects of Triazolam in Children." Pediatr Dent 21, no. 1 (1999): 18-25.

Conners, G. P. "Piperazine Neurotoxicity: Worm Wobble Revisited." J Emerg Med 13, no. 3 (1995): 341-3.

Coulter, D. M., I. R. Edwards, and R. L. Savage. "Survey of Neurological Problems with Amiodarone in the New Zealand Intensive Medicines Monitoring Programme." N Z Med J 103, no. 885 (1990): 98-100.

Craig, S. "Phenytoin Poisoning." Neurocrit Care 3, no. 2 (2005): 161-70.

Crawford, P., H. Meinardi, S. Brown, T. W. Rentmeester, B. Pedersen, P. C. Pedersen, and L. C. Lassen. "Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures." Epilepsia 42, no. 4 (2001): 531-8.

Curtis, D. L., R. Piibe, M. J. Ellenhorn, J. Wasserberger, and G. Ordog. "Phenytoin Toxicity: A Review of 94 Cases." Vet Hum Toxicol 31, no. 2 (1989): 164-5.

Dallocchio, C., C. Buffa, P. Mazzarello, and S. Chiroli. "Gabapentin Vs. Amitriptyline in Painful Diabetic Neuropathy: An Open-Label Pilot Study." J Pain Symptom Manage 20, no. 4 (2000): 280-5.

De Marco, S., E. Squilloni, L. Vigna, M. F. Bertagnolio, and C. N. Sternberg. "Irinotecan Chemotherapy Associated with Transient Dysarthria and Aphasia." Ann Oncol 15, no. 7 (2004): 1147-8.

Dean, C., M. Mosier, and K. Penry. "Dose-Response Study of Vigabatrin as Add-on Therapy in Patients with Uncontrolled Complex Partial Seizures." Epilepsia 40, no. 1 (1999): 74-82.

Dembowski, C., and T. Rechlin. "Successful Antimanic Treatment and Mood Stabilization with Lamotrigine, Clozapine, and Valproate in a Bipolar Patient after Lithium-Induced Cerebellar Deterioration. A Case Report." Pharmacopsychiatry 36, no. 2 (2003): 83-6.

Dennison, U., M. Clarkson, J. O'Mullane, and E. M. Cassidy. "The Incidence and Clinical Correlates of Lithium Toxicity: A Retrospective Review." Ir J Med Sci 180, no. 3 (2011): 661-5.

Dixon, R. A., N. R. Bennett, M. J. Harrison, C. Kenyon, and J. A. Thornton. "I.V. Flunitrazepam and I.V. Diazepam in Conservative Dentistry. A Cross-over Trial." Br J Anaesth 52, no. 5 (1980): 517-26.

Donaldson, I. M., and J. Cuningham. "Persisting Neurologic Sequelae of Lithium Carbonate Therapy." Arch Neurol 40, no. 12 (1983): 747-51.

Dorado, P., E. Lopez-Torres, E. M. Penas-Lledo, J. Martinez-Anton, and A. Llerena. "Neurological Toxicity after Phenytoin Infusion in a Pediatric Patient with Epilepsy: Influence of Cyp2c9, Cyp2c19 and Abcb1 Genetic Polymorphisms." Pharmacogenomics J 13, no. 4 (2013): 359-61.

Dreifuss, F. E., J. K. Penry, S. W. Rose, H. J. Kupferberg, P. Dyken, and S. Sato. "Serum Clonazepam Concentrations in Children with Absence Seizures." Neurology 25, no. 3 (1975): 255-8.

Dubey, A. K., R. K. Gupta, and R. K. Sharma. "Levamisole Induced Ataxia." Indian Pediatr 38, no. 4 (2001): 417-9.

Duchowny, M., J. M. Pellock, W. D. Graf, C. Billard, J. Gilman, E. Casale, G. Womble, M. Risner, and P. Manasco. "A Placebo-Controlled Trial of Lamotrigine Add-on Therapy for Partial Seizures in Children. Lamictal Pediatric Partial Seizure Study Group." Neurology 53, no. 8 (1999): 1724-31.

Dworkin, L. A., R. D. Goldman, L. S. Zivin, and P. C. Fuchs. "Cerebellar Toxicity Following High-Dose Cytosine Arabinoside." J Clin Oncol 3, no. 5 (1985): 613-6.

Dworkin, R. H., A. E. Corbin, J. P. Young, Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E. A. Garofalo, and R. M. Poole. "Pregabalin for the Treatment of Postherpetic Neuralgia: A Randomized, Placebo-Controlled Trial." Neurology 60, no. 8 (2003): 1274-83.

Early, A. P., H. D. Preisler, H. Slocum, and Y. M. Rustum. "A Pilot Study of High-Dose 1-Beta-D-Arabinofuranosylcytosine for Acute Leukemia and Refractory Lymphoma: Clinical Response and Pharmacology." Cancer Res 42, no. 4 (1982): 1587-94.

Elger, C., M. Bialer, J. A. Cramer, J. Maia, L. Almeida, and P. Soares-da-Silva. "Eslicarbazepine Acetate: A Double-Blind, Add-on, Placebo-Controlled Exploratory Trial in Adult Patients with Partial-Onset Seizures." Epilepsia 48, no. 3 (2007): 497-504.

Elger, C. E., M. J. Brodie, H. Anhut, C. M. Lee, and J. A. Barrett. "Pregabalin Add-on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible-Dose and Fixed-Dose Treatment in a Double-Blind, Placebo-Controlled Study." Epilepsia 46, no. 12 (2005): 1926-36.

Ellaway, C. J., B. Bennetts, R. R. Tuck, and B. Wilcken. "Clumsiness, Confusion, Coma, and Valproate." Lancet 353, no. 9162 (1999): 1408.

Ertan, S., M. O. Ulu, H. Hanimoglu, T. Tanriverdi, A. M. Kafadar, Z. U. Acar, and G. Kiziltan. "Phenytoin-Induced Parkinsonism." Singapore Med J 47, no. 11 (2006): 981-3.

Espay, A. J. "Reversible Parkinsonism and Ataxia Associated with High-Dose Octreotide." Neurology 70, no. 24 (2008): 2345-6.

Faught, E., R. Ayala, G. G. Montouris, I. E. Leppik, and Group Zonisamide 922 Trial. "Randomized Controlled Trial of Zonisamide for the Treatment of Refractory Partial-Onset Seizures." Neurology 57, no. 10 (2001): 1774-9.

Faught, E., B. J. Wilder, R. E. Ramsay, R. A. Reife, L. D. Kramer, G. W. Pledger, and R. M. Karim. "Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory Partial Epilepsy Using 200-, 400-, and 600-Mg Daily Dosages. Topiramate Yd Study Group." Neurology 46, no. 6 (1996): 1684-90.

Ferbert, A., and A. Czernik. "[Persistent Cerebellar Syndrome Following Lithium Poisoning]." Nervenarzt 58, no. 12 (1987): 764-70.

Fisher, R. S., R. C. Sachdeo, J. Pellock, P. E. Penovich, L. Magnus, and P. Bernstein. "Rapid Initiation of Gabapentin: A Randomized, Controlled Trial." Neurology 56, no. 6 (2001): 743-8.

Fisk, G. G., and S. M. York. "The Effect of Sodium Valproate on Tardive Dyskinesia--Revisited." Br J Psychiatry 150, (1987): 542-6.

Fogoros, R. N., K. P. Anderson, R. A. Winkle, C. D. Swerdlow, and J. W. Mason. "Amiodarone: Clinical Efficacy and Toxicity in 96 Patients with Recurrent, Drug-Refractory Arrhythmias." Circulation 68, no. 1 (1983): 88-94.

French, J. A., B. W. Abou-Khalil, R. F. Leroy, E. M. Yacubian, P. Shin, S. Hall, H. Mansbach, V. Nohria, and Restore Study 301 Investigators. "Randomized, Double-Blind, Placebo-Controlled Trial of Ezogabine (Retigabine) in Partial Epilepsy." Neurology 76, no. 18 (2011): 1555-63.

French, J. A., A. R. Kugler, J. L. Robbins, L. E. Knapp, and E. A. Garofalo. "Dose-Response Trial of Pregabalin Adjunctive Therapy in Patients with Partial Seizures." Neurology 60, no. 10 (2003): 1631-7.

Friedman, J. H., and N. Shetty. "Permanent Cerebellar Toxicity of Cytosine Arabinoside (Ara C) in a Young Woman." Mov Disord 16, no. 3 (2001): 575-7.

Gannaway, D. J., and G. E. Mawer. "Serum Phenytoin Concentration and Clinical Response in Patients with Epilepsy." Br J Clin Pharmacol 12, no. 6 (1981): 833-9.

Garretto, N. S., R. D. Rey, G. Kohler, S. Cocorullo, D. A. Monteverde, B. I. Ravera, and R. E. Sica. "[Cerebellar Syndrome Caused by Amiodarone]." Arq Neuropsiquiatr 52, no. 4 (1994): 575-7.

Garson, A., Jr., J. D. Kugler, P. C. Gillette, A. Simonelli, and D. G. McNamara. "Control of Late Postoperative Ventricular Arrhythmias with Phenytoin in Young Patients." Am J Cardiol 46, no. 2 (1980): 290-4.

Gil-Nagel, A., J. Lopes-Lima, L. Almeida, J. Maia, P. Soares-da-Silva, and B. I. A. Investigators Study Group. "Efficacy and Safety of 800 and 1200 Mg Eslicarbazepine Acetate as Adjunctive Treatment in Adults with Refractory Partial-Onset Seizures." Acta Neurol Scand 120, no. 5 (2009): 281-7.

Glasier, C. M., J. E. Stark, R. Brown, C. A. James, and J. W. Allison. "Rectal Thiopental Sodium for Sedation of Pediatric Patients Undergoing Mr and Other Imaging Studies." AJNR Am J Neuroradiol 16, no. 1 (1995): 111-4.

Gomceli, Y. B., G. Kutlu, L. Cavdar, F. Sanivar, and L. E. Inan. "Different Clinical Manifestations of Hyperammonemic Encephalopathy." Epilepsy Behav 10, no. 4 (2007): 583-7.

Gore, J. M., C. I. Haffajee, and J. S. Alpert. "Interaction of Amiodarone and Diphenylhydantoin." Am J Cardiol 54, no. 8 (1984): 1145.

Gottlieb, D., K. Bradstock, J. Koutts, T. Robertson, C. Lee, and P. Castaldi. "The Neurotoxicity of High-Dose Cytosine Arabinoside Is Age-Related." Cancer 60, no. 7 (1987): 1439-41.

Gottlieb, J. A., and J. K. Luce. "Cerebellar Ataxia with Weekly 5-Fluorouracil Administration." Lancet 1, no. 7690 (1971): 138-9.

Gram, L., P. Klosterskov, and M. Dam. "Gamma-Vinyl Gaba: A Double-Blind Placebo-Controlled Trial in Partial Epilepsy." Ann Neurol 17, no. 3 (1985): 262-6.

Graves, T. D., M. Condon, M. Loucaidou, and R. J. Perry. "Reversible Metronidazole-Induced Cerebellar Toxicity in a Multiple Transplant Recipient." J Neurol Sci 285, no. 1-2 (2009): 238-40.

Green, J. B. "Permanent Neurological Deficits Resulting from Lithium Toxicity." Ann Neurol 15, no. 1 (1984): 111.

Greene, H. L., E. L. Graham, J. A. Werner, G. K. Sears, B. W. Gross, J. P. Gorham, P. J. Kudenchuk, and G. B. Trobaugh. "Toxic and Therapeutic Effects of Amiodarone in the Treatment of Cardiac Arrhythmias." J Am Coll Cardiol 2, no. 6 (1983): 1114-28.

Grossman, L., M. A. Baker, D. M. Sutton, and J. H. Deck. "Central Nervous System Toxicity of High-Dose Cytosine Arabinoside." Med Pediatr Oncol 11, no. 4 (1983): 246-50.

Guerreiro, M. M., U. Vigonius, H. Pohlmann, M. L. de Manreza, N. Fejerman, S. A. Antoniuk, and A. Moore. "A Double-Blind Controlled Clinical Trial of Oxcarbazepine Versus Phenytoin in Children and Adolescents with Epilepsy." Epilepsy Res 27, no. 3 (1997): 205-13.

Gupta, V., T. P. Yadav, and A. Yadav. "Phenytoin Toxicity Presenting as Acute Meningo-Encephalitis in Children." Neurol India 59, no. 1 (2011): 66-7.

Hahn, K., G. Arendt, J. S. Braun, H. J. von Giesen, I. W. Husstedt, M. Maschke, M. E. Straube, E. Schielke, and Aids Working Group German Neuro. "A Placebo-Controlled Trial of Gabapentin for Painful Hiv-Associated Sensory Neuropathies." J Neurol 251, no. 10 (2004): 1260-6.

Halasz, P., R. Kalviainen, M. Mazurkiewicz-Beldzinska, F. Rosenow, P. Doty, D. Hebert, T. Sullivan, and S. P. Study Group. "Adjunctive Lacosamide for Partial-Onset Seizures: Efficacy and Safety Results from a Randomized Controlled Trial." Epilepsia 50, no. 3 (2009): 443-53.

Hamberg, P., F. A. De Jong, D. Brandsma, J. Verweij, and S. Sleijfer. "Irinotecan-Induced Central Nervous System Toxicity. Report on Two Cases and Review of the Literature." Acta Oncol 47, no. 5 (2008): 974-8.

Hamberg, P., R. C. Donders, and D. ten Bokkel Huinink. "Central Nervous System Toxicity Induced by Irinotecan." J Natl Cancer Inst 98, no. 3 (2006): 219.

Hamer, H. M., S. Knake, U. Schomburg, and F. Rosenow. "Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate." Neurology 54, no. 1 (2000): 230-2.

Hansen, R., E. Quebbeman, P. Ritch, C. Chitambar, and T. Anderson. "Continuous 5-Fluorouracil (5fu) Infusion in Carcinoma of the Pancreas: A Phase Ii Study." Am J Med Sci 295, no. 2 (1988): 91-3.

Hari, A., B. A. Srikanth, and G. S. Lakshmi. "Metronidazole Induced Cerebellar Ataxia." Indian J Pharmacol 45, no. 3 (2013): 295-7.

Hasle, H. "Cerebellar Toxicity During Cytarabine Therapy Associated with Renal Insufficiency." Cancer Chemother Pharmacol 27, no. 1 (1990): 76-8.

Heaney, C. J., N. G. Campeau, and E. P. Lindell. "Mr Imaging and Diffusion-Weighted Imaging Changes in Metronidazole (Flagyl)-Induced Cerebellar Toxicity." AJNR Am J Neuroradiol 24, no. 8 (2003): 1615-7.

Hellden, A., U. Bergman, K. Engstrom Hellgren, M. Masquelier, I. Nilsson Remahl, I. Odar-Cederlof, M. Ramsjo, and L. Bertilsson. "Fluconazole-Induced Intoxication with Phenytoin in a Patient with Ultra-High Activity of Cyp2c9." Eur J Clin Pharmacol 66, no. 8 (2010): 791-5.

Herold, T. J. "Lamotrigine as a Possible Cause of Qrs Prolongation in a Patient with Known Seizure Disorder." CJEM 8, no. 5 (2006): 361-4.

Herzig, R. H., J. D. Hines, G. P. Herzig, S. N. Wolff, P. A. Cassileth, H. M. Lazarus, D. J. Adelstein, R. A. Brown, P. F. Coccia, S. Strandjord, and et al. "Cerebellar Toxicity with High-Dose Cytosine Arabinoside." J Clin Oncol 5, no. 6 (1987): 927-32.

Hindle, J. V., A. Ibrahim, and R. Ramaraj. "Ataxia Caused by Amiodarone in Older People." Age Ageing 37, no. 3 (2008): 347-8.

Hofstra, L. S., W. T. van der Graaf, E. G. de Vries, H. Haaxma-Reiche, and P. H. Willemse. "Ataxia Following Docetaxel Infusion." Ann Oncol 8, no. 8 (1997): 812-3.

Hommet, C., K. Mondon, B. de Toffol, and T. Constans. "Reversible Cognitive and Neurological Symptoms During Valproic Acid Therapy." J Am Geriatr Soc 55, no. 4 (2007): 628.

Huan, S., R. Pazdur, A. Singhakowinta, B. Samal, and V. K. Vaitkevicius. "Low-Dose Continuous Infusion 5-Fluorouracil. Evaluation in Advanced Breast Carcinoma." Cancer 63, no. 3 (1989): 419-22.

Huber, B., and M. Tomka-Hoffmeister. "Limited Efficacy of Gabapentin in Severe Therapy-Resistant Epilepsies of Learning-Disabled Patients." Seizure 12, no. 8 (2003): 602-3.

Ilagan, M. C., D. Carlson, and J. F. Madden. "Lithium Toxicity: Two Case Reports." Del Med J 74, no. 6 (2002): 263-70.